CARF Is a Vital Dual Regulator of Cellular Senescence and Apoptosis

被引:37
作者
Hasan, Md. Kamrul [1 ]
Cheung, Caroline [1 ]
Kaul, Zeenia [1 ,2 ]
Shah, Navjot [1 ]
Sakaushi, Shinji [3 ]
Sugimoto, Kenji [3 ]
Oka, Shigenori [3 ,4 ]
Kaul, Sunil C. [1 ]
Wadhwa, Renu [1 ]
机构
[1] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan
[2] Univ Sydney, Childrens Med Res Inst, Fac Med, Westmead, NSW 2145, Australia
[3] Osaka Prefecture Univ, Lab Mol Biol & Cell Informat, Grad Sch Life & Environm Sci, Naka Ku, Osaka 5998531, Japan
[4] Nagase & Co Ltd, Recombinant Prot Developing Team, Ctr Res & Dev, Nishi Ku, Kobe, Hyogo 6512241, Japan
关键词
ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE; HISTONE H3; CENTROSOME DUPLICATION; CANCER DEVELOPMENT; TUMOR SUPPRESSION; HUMAN FIBROBLASTS; P53; RESTORATION; PROTEIN; PHOSPHORYLATION;
D O I
10.1074/jbc.M805778200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor protein, p53, is central to the pathways that monitor the stress, DNA damage repair, cell cycle, aging, and cancer. Highly complex p53 networks involving its upstream sensors and regulators, downstream effectors and regulatory feedback loops have been identified. CARF (Collaborator of ARF) was shown to enhance ARF-dependent and -independent wild-type p53 function. Here we report that (i) CARF overexpression causes premature senescence of human fibroblasts, (ii) it is vital for replicative and stress-induced senescence, and (iii) the lack of CARF function causes aneuploidy and apoptosis. We provide evidence that CARF plays a dual role in regulating p53-mediated senescence and apoptosis, the two major tumor suppressor mechanisms.
引用
收藏
页码:1664 / 1672
页数:9
相关论文
共 38 条
[1]   Mdm2 and Mdm4 loss regulates distinct p53 activities [J].
Barboza, Juan A. ;
Iwakuma, Tomoo ;
Terzian, Tamara ;
El-Naggar, Adel K. ;
Lozano, Guillermina .
MOLECULAR CANCER RESEARCH, 2008, 6 (06) :947-954
[2]   DNA damage signalling guards against activated oncogenes and tumour progression [J].
Bartek, J. ;
Bartkova, J. ;
Lukas, J. .
ONCOGENE, 2007, 26 (56) :7773-7779
[3]   Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints [J].
Bartkova, Jirina ;
Rezaei, Nousin ;
Liontos, Michalis ;
Karakaidos, Panagiotis ;
Kletsas, Dimitris ;
Issaeva, Natalia ;
Vassiliou, Leandros-Vassilios F. ;
Kolettas, Evangelos ;
Niforou, Katerina ;
Zoumpourlis, Vassilis C. ;
Takaoka, Munenori ;
Nakagawa, Hiroshi ;
Tort, Frederic ;
Fugger, Kasper ;
Johansson, Fredrik ;
Sehested, Maxwell ;
Andersen, Claus L. ;
Dyrskjot, Lars ;
Orntoft, Torben ;
Lukas, Jiri ;
Kittas, Christos ;
Helleday, Thomas ;
Halazonetis, Thanos D. ;
Bartek, Jiri ;
Gorgoulis, Vassilis G. .
NATURE, 2006, 444 (7119) :633-637
[4]   Bypass of senescence after disruption of p21(CIP1/WAF1) gene in normal diploid human fibroblasts [J].
Brown, JP ;
Wei, WY ;
Sedivy, JM .
SCIENCE, 1997, 277 (5327) :831-834
[5]   Aging and cancer cell biology, 2007 [J].
Campisi, Judith .
AGING CELL, 2007, 6 (03) :261-263
[6]  
CHEUNG CT, 2008, MECH AGEING IN PRESS
[7]   Centrosome amplification, chromosome instability and cancer development [J].
Fukasawa, K .
CANCER LETTERS, 2005, 230 (01) :6-19
[8]   p53, cyclin-dependent kinase and abnormal amplification of centrosomes [J].
Fukasawa, Kenji .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2008, 1786 (01) :15-23
[9]   Senescence: a telomeric limit to immortality or a cellular response to physiologic stresses? [J].
Gire, V .
M S-MEDECINE SCIENCES, 2005, 21 (05) :491-497
[10]  
Gniadecki R, 2000, CELL MOL BIOL, V46, P121